Center for Alcohol and Addiction Studies, Brown University
Providence, Rhode Island, 02919, United States
NCT Number: NCT00006203
This 5-week study will examine the effects of naltrexone on alcohol craving, drinking rates, and reaction to drinking-related triggers, or cues, in participants' everyday environment and in laboratory sessions. Participants will monitor and record their daily desires to drink, environmental circumstances in which urges occur, and drinking behavior using a palm top computer. Participants will receive naltrexone or a placebo. One week after receiving medication, all participants will be asked to respond to alcohol-related cues that may or may not arouse the desire to drink.
Looking for future studies?
Notify Me21 year and older
All sexes
Interventional
Phase 4
Providence, Rhode Island, 02919, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Daily 50 mg for 3 weeks
Daily doses of placebo for 3 weeks
Brown University
Other
Naltrexone, Craving, and Drinking: Ecological Assessment
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03152760
Alcohol-Related Disorders, Alcoholism
Bethesda, Maryland, United States
View Trial DetailsNCT02181569
Alcohol-Related Disorders, Alcoholism
Bethesda, Maryland, United States
View Trial DetailsNCT03120468
Alcohol-Related Disorders, Alcoholism
Charlottesville, Virginia, United States
View Trial DetailsNCT03969251
Alcohol-Related Disorders, Alcoholism
Charlottesville, Virginia, United States
View Trial Details